| ![](/p.gif) |
![](/p.gif) |
| Artikel-Nr.: 5667A-9783030069803 Herst.-Nr.: 9783030069803 EAN/GTIN: 9783030069803 |
| |
|
| ![](/p.gif) | ![](/p.gif) |
![](/p.gif) | This volume describes our current understanding of the biological role of the delta-opioid receptor (DOR) system, focusing on its unique mechanisms of receptor trafficking and signaling in disease states. Part 1 covers the endogenous ligands that regulate the DOR system as well as novel compounds and therapies used to modulate the DOR system. Part 2 describes new insights into the localization and trafficking of the DOR and how ligand-directed signaling alters the fate of the receptor. Part 3 concentrates on the potential role of the DOR system in disease states, such as pain, mood, addiction, and Parkinson's disease. Throughout the book, the DOR system as a target for drug development will be discussed. Weitere Informationen: ![](/p.gif) | ![](/p.gif) | Author: | Emily M. Jutkiewicz | Verlag: | Springer International Publishing | Sprache: | eng |
|
| ![](/p.gif) | ![](/p.gif) |
![](/p.gif) | | ![](/p.gif) | ![](/p.gif) |
![](/p.gif) | Weitere Suchbegriffe: CNS-relateddiseases; Enkephalin; biasedagonism; drugdevelopment; pain,emotionandaddiction; receptortrafficking, CNS-related diseases, Enkephalin, biased agonism, drug development, pain, emotion and addiction, receptor trafficking |
| ![](/p.gif) | ![](/p.gif) |
| |